Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 3 |
2014 | 2 |
2015 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia.
Br J Haematol. 2015 Apr;169(2):199-210. doi: 10.1111/bjh.13281. Epub 2015 Feb 2.
Br J Haematol. 2015.
PMID: 25643589
Free article.
Clinical Trial.
Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
Govindaraj C, Madondo M, Kong YY, Tan P, Wei A, Plebanski M.
Govindaraj C, et al.
Am J Hematol. 2014 Aug;89(8):795-802. doi: 10.1002/ajh.23746. Epub 2014 May 16.
Am J Hematol. 2014.
PMID: 24757092
Free article.
Clinical Trial.
Item in Clipboard
Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
Govindaraj C, Tan P, Walker P, Wei A, Spencer A, Plebanski M.
Govindaraj C, et al.
Clin Cancer Res. 2014 Feb 1;20(3):724-35. doi: 10.1158/1078-0432.CCR-13-1576. Epub 2013 Dec 2.
Clin Cancer Res. 2014.
PMID: 24297862
Clinical Trial.
Item in Clipboard
TNFR2 Expression on CD25(hi)FOXP3(+) T Cells Induced upon TCR Stimulation of CD4 T Cells Identifies Maximal Cytokine-Producing Effectors.
Govindaraj C, Scalzo-Inguanti K, Scholzen A, Li S, Plebanski M.
Govindaraj C, et al.
Front Immunol. 2013 Aug 6;4:233. doi: 10.3389/fimmu.2013.00233. eCollection 2013.
Front Immunol. 2013.
PMID: 23964278
Free PMC article.
Item in Clipboard
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
Govindaraj C, Scalzo-Inguanti K, Madondo M, Hallo J, Flanagan K, Quinn M, Plebanski M.
Govindaraj C, et al.
Clin Immunol. 2013 Oct;149(1):97-110. doi: 10.1016/j.clim.2013.07.003. Epub 2013 Jul 25.
Clin Immunol. 2013.
PMID: 23948613
Item in Clipboard
Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy.
Park A, Govindaraj C, Xiang SD, Halo J, Quinn M, Scalzo-Inguanti K, Plebanski M.
Park A, et al. Among authors: govindaraj c.
Cancers (Basel). 2012 Jun 18;4(2):581-600. doi: 10.3390/cancers4020581.
Cancers (Basel). 2012.
PMID: 24213326
Free PMC article.
Item in Clipboard
Cite
Cite